Evidence map›Paper›PMID 39428877›Full record

ArticlePhilosophical transactions of the Royal Society of London. Series B, Biological sciences2024

Amygdala self-neuromodulation capacity as a window for process-related network recruitment.

Guy Gurevitch, Nitzan Lubianiker, Taly Markovits, Ayelet Or-Borichev, Haggai Sharon, Naomi B Fine, Tom Fruchtman-Steinbok, Jacob N Keynan, Moni Shahar, Alon Friedman and 2 more

Abstract read
In one paragraph

Article in Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Neurofeedback: new territories and neurocognitive mechanisms of endogenous neuromodulation.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2024
    Article
  8. Amygdala self-neuromodulation capacity as a window for process-related network recruitment.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Guy GurevitchSagol Brain Institute, Tel Aviv Sourasky Medical Center , Tel Aviv-Yafo, Israel.ORCID 0000-0001-9245-6838
Nitzan LubianikerSagol Brain Institute, Tel Aviv Sourasky Medical Center , Tel Aviv-Yafo, Israel.
Taly MarkovitsSagol Brain Institute, Tel Aviv Sourasky Medical Center , Tel Aviv-Yafo, Israel.
Ayelet Or-BorichevSagol Brain Institute, Tel Aviv Sourasky Medical Center , Tel Aviv-Yafo, Israel.
Haggai SharonSagol Brain Institute, Tel Aviv Sourasky Medical Center , Tel Aviv-Yafo, Israel.
Naomi B FineSagol Brain Institute, Tel Aviv Sourasky Medical Center , Tel Aviv-Yafo, Israel.
Tom Fruchtman-SteinbokSagol Brain Institute, Tel Aviv Sourasky Medical Center , Tel Aviv-Yafo, Israel.
Jacob N KeynanSagol Brain Institute, Tel Aviv Sourasky Medical Center , Tel Aviv-Yafo, Israel.
Moni ShaharThe Center for AI and Data Science, Tel Aviv University , Tel Aviv-Yafo, Israel.
Alon FriedmanBen-Gurion University of the Negev , Be'er Sheva, Israel.
Neomi SingerSagol Brain Institute, Tel Aviv Sourasky Medical Center , Tel Aviv-Yafo, Israel.
Talma HendlerSagol Brain Institute, Tel Aviv Sourasky Medical Center , Tel Aviv-Yafo, Israel.ORCID 0000-0002-4182-4335

Funding

Deutsche ForschungsgemeinschaftIsrael Science FoundationSeventh Framework Programme
6 · The paper itself

Abstract

Neurofeedback (NF) has emerged as a promising avenue for demonstrating process-related neuroplasticity, enabling self-regulation of brain function. NF targeting the amygdala has drawn attention to therapeutic potential in psychiatry, by potentially harnessing emotion-regulation processes. However, not all individuals respond equally to NF training, possibly owing to varying self-regulation abilities. This underscores the importance of understanding the mechanisms behind successful neuromodulation (i.e. capacity). This study aimed to investigate the establishment and neural correlates of neuromodulation capacity using data from repeated sessions of amygdala electrical fingerprint (Amyg-EFP)-NF and post-training functional magnetic resonance imaging (fMRI)-NF sessions. Results from 97 participants (healthy controls and post-traumatic stress disorder and fibromyalgia patients) revealed increased Amyg-EFP neuromodulation capacity over training, associated with post-training amygdala-fMRI modulation capacity and improvements in alexithymia. Individual differenaces in this capacity were associated with pre-training amygdala reactivity and initial neuromodulation success. Additionally, amygdala downregulation during fMRI-NF co-modulated with other regions such as the posterior insula and parahippocampal gyrus. This combined modulation better explained EFP-modulation capacity and improvement in alexithymia than the amygdala modulation alone, suggesting the relevance of this broader network to gained capacity. These findings support a network-based approach for NF and highlight the need to consider individual differences in brain function and modulation capacity to optimize NF interventions. This article is part of the theme issue 'Neurofeedback: new territories and neurocognitive mechanisms of endogenous neuromodulation'.

Indexed as

AmygdalaMagnetic Resonance ImagingNeurofeedbackAdultFemaleHumansMaleMiddle AgedNeuronal PlasticityStress Disorders, Post-TraumaticYoung AdultamygdalaEEGfunctional MRIneurofeedbackneuromodulationneuroplasticity

Identifiers

PMID39428877
PMCPMC11491848

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.